2016
March
Type 1 Diabetes - a risk in particular for young people - is due to an auto-immune reaction, in which an ill-guided immune reaction kills the beta cells in the pancreas, which are responsible for the synthesis of insulin. There is now a trial in London of an immunotherapy treatment to halt the progression of this. |